These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4648492)

  • 1. Synthesis of lividomycin A 5''-phosphate, an enzymatically inactivated lividomycin A.
    Yamamoto H; Kondo S; Maeda K; Umezawa H
    J Antibiot (Tokyo); 1972 Aug; 25(8):485-6. PubMed ID: 4648492
    [No Abstract]   [Full Text] [Related]  

  • 2. A facile synthesis of derivatives of lividosamine, a component of lividomycin B.
    Jegou E; Cleophax J; Leboul J; Gero SD
    Carbohydr Res; 1975 Dec; 45():323-6. PubMed ID: 1044289
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Synthesis of 1-N-((s)-4-amino-2-hydroxybutyryl)lividomycin A.
    Watanabe I; Tsuchiya T; Umezawa S; Umezawa H
    J Antibiot (Tokyo); 1973 May; 26(5):310-2. PubMed ID: 4780814
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis.
    Tsukamura M; Mizuno S
    J Gen Microbiol; 1975 Jun; 88(2):269-74. PubMed ID: 50402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies on the activities of lividomycin 5''-phosphate and lividomycin on polypeptide synthesis directed by poly U in E. coli cell-free extracts.
    Yamaguchi M; Kobayashi F; Mitsuhashi S
    J Antibiot (Tokyo); 1973 Oct; 26(10):602-5. PubMed ID: 4599521
    [No Abstract]   [Full Text] [Related]  

  • 6. Coupling of drug protonation to the specific binding of aminoglycosides to the A site of 16 S rRNA: elucidation of the number of drug amino groups involved and their identities.
    Kaul M; Barbieri CM; Kerrigan JE; Pilch DS
    J Mol Biol; 2003 Mar; 326(5):1373-87. PubMed ID: 12595251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of lividomycin A inactivated by Pseudomonas aeruginosa and Escherichia coli carrying R factor.
    Kondo S; Yamamoto H; Naganawa H; Umezawa H
    J Antibiot (Tokyo); 1972 Aug; 25(8):483-4. PubMed ID: 4630725
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical effect of lividomycin on gonorrhea and lividomycin sensitivity of gonococci (author's transl)].
    Toda H
    Jpn J Antibiot; 1974 Dec; 27(6):775-8. PubMed ID: 4219033
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis of paromomycin derivatives modified at C(5'') to selectively target bacterial rRNA.
    Kudyba I; Fernandez DP; Böttger EC; Vasella A
    Carbohydr Res; 2007 Feb; 342(3-4):499-519. PubMed ID: 17049499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experiences of lividomycin on respiratory tract infections (author's transl)].
    Kondo H; Miwa T; Suhachiro M; Yokouchi S; Ando Y
    Jpn J Antibiot; 1975 Apr; 28(2):149-54. PubMed ID: 1041282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 5''-deoxylividomycin B.
    Umezawa S; Watanabe I; Tshchiya T; Umezawa H; Hamada M
    J Antibiot (Tokyo); 1972 Oct; 25(10):617-8. PubMed ID: 4648316
    [No Abstract]   [Full Text] [Related]  

  • 12. Semisynthetic aminoglycoside antibiotics. I. New reactions of paromomycin and synthesis of its 2'-N-ethylderivative.
    Cassinelli G; Franceschi G; Di Colo G; Arcamone F
    J Antibiot (Tokyo); 1978 Apr; 31(4):379-81. PubMed ID: 659336
    [No Abstract]   [Full Text] [Related]  

  • 13. Semisynthetic aminoglycoside antibiotics. II. Synthesis of analogues of paromomycin modified in the glucosamine moiety.
    Cassinelli G; Julita P; Arcamone F
    J Antibiot (Tokyo); 1978 Apr; 31(4):382-4. PubMed ID: 659337
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of resistance to aminoglycoside antibiotics in nebramycin-producing Streptomyces tenebrarius.
    Yamamoto H; Hotta K; Okami Y; Umezawa H
    J Antibiot (Tokyo); 1982 Aug; 35(8):1020-5. PubMed ID: 7142002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ototoxicity of aminoglucosides. A case of deafness after lividomycin].
    Kuntzmann F; Weiss JM; Berthel M; Colonna JC; Conraux C; Reinhardt W; Brogard JM; Federspil P
    Nouv Presse Med; 1979 Apr; 8(19):1604-5. PubMed ID: 258790
    [No Abstract]   [Full Text] [Related]  

  • 16. [In-vitro antibacterial activity of an aminoglucoside antibiotic: lividomycin A].
    Marmo E; Cazzola M; Brita G; Paciello C
    Arch Monaldi; 1975; 30(4):287-310. PubMed ID: 1047630
    [No Abstract]   [Full Text] [Related]  

  • 17. [In-vivo antibacterial activity of an aminoglucoside antibiotic: lividomycin A].
    Marmo E; Cazzola M; Brita G; Paciello C
    Arch Monaldi; 1975; 30(4):311-7. PubMed ID: 779697
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental studies on the pharmacokinetics of lividomycin A].
    Marmo E; Cazzola M; Brita G; Paciello C
    Arch Monaldi; 1975; 30(4):279-86. PubMed ID: 1047629
    [No Abstract]   [Full Text] [Related]  

  • 19. Deneosaminyllividomycin B.
    Yamaguchi T; Kamiya K; Mori T; Oda T
    J Antibiot (Tokyo); 1977 Apr; 30(4):332-3. PubMed ID: 585689
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic effect of lividomycin on infections of the respiratory tract (author's transl)].
    Tsukamura M
    Jpn J Antibiot; 1975 Apr; 28(2):143-8. PubMed ID: 807755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.